AIMOVIG vs AIRSUPRA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. AIMOVIG and AIRSUPRA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	AIRSUPRA
Rating	72/100	70/100
Pharmacy pays	—	~$11.30 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	ALBUTEROL SULFATE AND BUDESONIDE
Manufacturer	Amgen Inc	Astrazeneca
Dosage forms	Injectable, Solution	Spray/Inhaler, metered
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 2 to 3.6 hours (terminal elimination half-life, measured after intravenous dosing)

aimovig airsupra

Rating

72/100

70/100

Pharmacy pays

—

~$11.30 /30

Type

Active ingredient

ERENUMAB-AOOE

ALBUTEROL SULFATE AND BUDESONIDE

Manufacturer

Amgen Inc

Astrazeneca

Dosage forms

Injectable, Solution

Spray/Inhaler, metered

Drug class

—

Boxed warning

None

Half-life

—

about 2 to 3.6 hours (terminal elimination half-life, measured after intravenous dosing)

Frequently asked questions

Which is better-rated, Aimovig or Airsupra?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Airsupra. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Airsupra?

Aimovig contains Erenumab-Aooe, while Airsupra contains Albuterol Sulfate and Budesonide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.